Search results
Eli Lilly’s and AstraZeneca’s Former Head of Research Dr. Jan Lundberg Elected as a New Board Member
Digital Journal· 6 days agoProfessor Jan Lundberg has more than 25 years of experience from leading positions in global pharmaceutical companies, including as global head of research ...
Pharma industry manufacturer Particle Dynamics names new CFO - St. Louis Business Journal
The Business Journals· 4 days agoParticle Dynamics, a provider of products and technologies for the pharmaceutical industry, has...
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Zacks via Yahoo Finance· 6 days agoHealthcare - Pharma is one of the 16 broad Zacks sectors within the Zacks Industry classification....
Earnings call: Flora Growth Corp. sees potential in German market, trims losses By Investing.com
Investing.com· 4 days agoFlora Growth Corp. (NASDAQ: FLGC), a player in the global cannabis market, reported its Q1 2024...
Earnings call: Flora Growth Corp. sees potential in German market, trims losses
Investing.com· 4 days agoFlora Growth Corp. (NASDAQ: FLGC), a player in the global cannabis market, reported its Q1 2024...
AstraZeneca prepares fresh COVID push to regulators after antibody's phase 3 success
FierceBiotech· 6 days agoWhile AstraZeneca’s globally used COVID-19 vaccine is leaving the scene, the British Big Pharma is...
Vicore Announces Positive Final Results from the Phase 2a AIR Trial Demonstrating Buloxibutid...
Digital Journal· 1 day agoVicore plans to progress buloxibutid to Phase 2b development in the first half of this year. Stockholm, May 20, 2024- Vicore Pharma Holding AB (STO: VICO), a clinical-stage ...
3 Healthcare Stocks to Buy Now: May 2024
InvestorPlace· 5 hours agoIt’s a great time to be looking at healthcare stocks to buy now. According to research from BlackRock, U.S. healthcare stocks have outperformed the...
University of Maryland School of Medicine Launches | Newswise
Newswise· 19 hours agoUniversity of Maryland School of Medicine (UMSOM) researchers at the Center for Vaccine Development and Global Health (CVD) have been awarded $3.96 million to develop a maternal ...
Algernon Pharmaceuticals Engages ICP Securities Inc. for Automated Market Making Services
Digital Journal· 13 hours agoAlgernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is ...
